首頁 > 市場調查報告書 > 消費品

市場調查報告書

商品編碼

1716516

麻醉霜市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Numbing Cream Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年03月26日 | 出版商:

Global Market Insights Inc. | 英文 487 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球麻醉霜市場價值為 36 億美元，預計 2025-2034 年期間複合年成長率為 6%。麻醉霜在醫療保健和美容領域中得到越來越廣泛的應用，以減輕注射、驗血和小手術等各種手術過程中的疼痛和不適。隨著門診手術的不斷增加以及患者的舒適度仍然是首要考慮因素，對有效麻醉霜的需求正在顯著成長。除了醫療保健應用之外，這些乳霜還廣泛用於皮膚病學和美容治療，例如雷射除毛、紋身和微刀片，其中減輕疼痛至關重要。隨著人們越來越重視提高患者體驗，麻醉霜在減輕焦慮和提高治療期間的整體滿意度方面發揮著至關重要的作用。由於微創美容手術的日益普及和疼痛管理解決方案的進步，市場正在經歷快速成長。此外，人們對美容和醫療過程中緩解疼痛的認知不斷提高，推動了全球範圍內麻醉霜的採用。

麻醉霜市場分為三類產品：局部麻醉霜、局部止痛藥和其他產品。 2024 年，局部麻醉霜市場的估值為 25 億美元，預計 2025-2034 年期間的複合年成長率為 6.2%。局部麻醉霜廣泛用於小手術、皮膚病治療和美容介入。這些藥膏通常含有丙胺卡因、利多卡因或苯佐卡因等活性成分，透過暫時阻斷皮膚神經訊號來麻痺治療區域。對無痛皮膚病和美容治療的需求不斷成長，推動了這些藥膏的採用，特別是在已開發經濟體中，患者優先考慮舒適度和最短的停機時間。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	36億美元
預測值	64億美元
複合年成長率	6%

就應用而言，市場分為美容手術、醫療應用和疼痛管理。 2024 年，美容手術領域佔據 46% 的佔有率，預計到 2034 年將以 6.5% 的複合年成長率成長。隨著對微創美容手術的需求持續激增，麻醉霜變得越來越重要，以確保治療過程中無痛舒適的體驗，否則可能會導致不適。微晶換膚、雷射換膚和肉毒桿菌注射等治療方法越來越受到人們的歡迎，而麻醉霜在提高患者的舒適度和滿意度方面發揮關鍵作用。

2024 年，北美佔據了全球麻醉霜市場的 26.4%。該地區廣泛採用非侵入性美容治療，例如除毛和皮膚年輕化，而麻醉霜對於減輕不適至關重要。對疼痛最小、恢復期較短的美容手術的需求不斷成長，推動了北美麻醉霜市場的成長。此外，消費者對疼痛管理解決方案的認知不斷提高以及配方技術的進步也促進了該地區麻醉霜的採用率不斷上升。

產業生態系統分析
供應商格局
定價分析
技術與創新格局
重要新聞和舉措
監管格局
製造商
經銷商
零售商
衝擊力
- 成長動力
  - 醫療程序和疼痛管理
  - 美容和整形治療
  - 提高消費者對疼痛管理的認知
  - 技術進步
- 產業陷阱與挑戰
  - 監理合規性
  - 安全問題
成長潛力分析
消費者購買行為
波特的分析
PESTEL分析

第4章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第5章：市場估計與預測：依產品類型，2021-2034

主要趨勢
局部麻醉藥膏
局部止痛藥
其他

第6章：市場估計與預測：按應用，2021-2034

主要趨勢
美容手術
醫療用途
疼痛管理

第7章：市場估計與預測：依價格區間，2021-2034

主要趨勢
低的
中
高的

第8章：市場估計與預測：依最終用途，2021-2034

主要趨勢
家庭使用
醫院和診所
美容院
其他（刺青店等）

第9章：市場估計與預測：按配銷通路，2021-2034

主要趨勢
網路零售
藥局和藥局
醫療用品經銷商

第10章：市場估計與預測：按地區，2021-2034

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
拉丁美洲
- 巴西
- 墨西哥
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 11 章：公司簡介

Blue Gel
Dr. Numb
Ebanel Laboratories
Hush Anesthetic
Lidocaine Plus
LMX4
Numb 520
Numb Master
Numb Max
Numbify
NumbSkin
Uber Numb
UltraNumb
Zensa

簡介目錄

Product Code: 10279

The Global Numbing Cream Market was valued at USD 3.6 billion in 2024 and is projected to grow at a CAGR of 6% during 2025-2034. Numbing creams are increasingly used across healthcare and cosmetic settings to alleviate pain and discomfort during various procedures, including injections, blood tests, and minor surgeries. As outpatient procedures continue to rise and patient comfort remains a priority, the demand for effective numbing creams is growing significantly. In addition to healthcare applications, these creams are also widely used in dermatology and cosmetic treatments, such as laser hair removal, tattooing, and microblading, where minimizing pain is crucial. With a growing emphasis on enhancing patient experience, numbing creams are playing an essential role in reducing anxiety and improving overall satisfaction during treatments. The market is experiencing rapid growth due to the increasing popularity of minimally invasive cosmetic procedures and advancements in pain management solutions. Moreover, the growing awareness regarding pain relief options during aesthetic and medical procedures is driving the adoption of numbing creams worldwide.

The numbing cream market is segmented into three product categories: topical anesthetic creams, topical analgesics, and other variants. In 2024, the topical anesthetic creams segment garnered a valuation of USD 2.5 billion and is expected to grow at a CAGR of 6.2% during 2025-2034. Topical anesthetic creams are extensively used in minor surgeries, dermatological treatments, and cosmetic interventions. These creams typically contain active ingredients such as prilocaine, lidocaine, or benzocaine, which work by temporarily blocking nerve signals in the skin to numb the treated area. The growing demand for pain-free dermatological and cosmetic treatments is driving the adoption of these creams, particularly in developed economies where patients prioritize comfort and minimal downtime.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$3.6 Billion
Forecast Value	$6.4 Billion
CAGR	6%

In terms of applications, the market is categorized into cosmetic procedures, medical applications, and pain management. The cosmetic procedures segment held a 46% share in 2024 and is expected to grow at 6.5% CAGR through 2034. As the demand for minimally invasive cosmetic procedures continues to surge, numbing creams are becoming essential to ensure a painless and comfortable experience during treatments that may otherwise cause discomfort. Treatments such as microdermabrasion, laser skin resurfacing, and botox injections are witnessing increased adoption, with numbing creams playing a pivotal role in enhancing patient comfort and satisfaction.

North America held a 26.4% share of the global numbing cream market in 2024. The region has witnessed widespread adoption of non-invasive cosmetic treatments, such as hair removal and skin rejuvenation, where numbing creams are vital for reducing discomfort. The increasing demand for aesthetic procedures with minimal pain and shorter recovery periods is driving the growth of the numbing cream market in North America. Additionally, growing consumer awareness of pain management solutions and advancements in formulation technology have contributed to the rising adoption of numbing creams in the region.

Chapter 1 Methodology & Scope

1.1 Research design
- 1.1.1 Research approach
- 1.1.2 Data collection methods
1.2 Base estimates and calculations
- 1.2.1 Base year calculation
- 1.2.2 Key trends for market estimates
1.3 Forecast model
1.4 Primary research & validation
- 1.4.1 Primary sources
- 1.4.2 Data mining sources
  - 1.4.2.1 Market definitions

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis, 2021-2034

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Supplier landscape
3.3 Pricing analysis
3.4 Technology & innovation landscape
3.5 Key news & initiatives
3.6 Regulatory landscape
3.7 Manufacturers
3.8 Distributors
3.9 Retailers
3.10 Impact forces
- 3.10.1 Growth drivers
  - 3.10.1.1 Medical procedures and pain management
  - 3.10.1.2 Cosmetic and aesthetic treatments
  - 3.10.1.3 Increasing consumer awareness on pain management
  - 3.10.1.4 Technological advances
- 3.10.2 Industry pitfalls & challenges
  - 3.10.2.1 Regulatory compliance
  - 3.10.2.2 Safety concerns
3.11 Growth potential analysis
3.12 Consumer buying behavior
3.13 Porter's analysis
3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2034 (USD Billion) (Million Units)

5.1 Key trends
5.2 Topical anesthetic creams
5.3 Topical analgesics
5.4 Others

Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion) (Million Units)

6.1 Key trends
6.2 Cosmetic procedure
6.3 Medical purposes
6.4 Pain management

Chapter 7 Market Estimates & Forecast, By Price Range, 2021-2034 (USD Billion) (Million Units)

7.1 Key trends
7.2 Low
7.3 Mid
7.4 High

Chapter 8 Market Estimates & Forecast, By End Use, 2021-2034 (USD Billion) (Million Units)

8.1 Key trends
8.2 Home use
8.3 Hospitals and clinics
8.4 Beauty parlors
8.5 Others (tattoo parlors, etc.)

Chapter 9 Market Estimates & Forecast, By Distribution Channel, 2021-2034 (USD Billion) (Million Units)

9.1 Key trends
9.2 Online retail
9.3 Pharmacies and drug stores
9.4 Medical supply distributors

Chapter 10 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Million Units)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 UK
- 10.3.2 Germany
- 10.3.3 France
- 10.3.4 Italy
- 10.3.5 Spain
- 10.3.6 Russia
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 South Korea
- 10.4.5 Australia
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
10.6 MEA
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE